INMODE LTD (INMD) Stock Fundamental Analysis
USA - NASDAQ:INMD - IL0011595993 - Common Stock
13.76 USD
-0.41 (-2.89%)
INMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on INMD. This makes INMD very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year INMD was profitable.
In the past year INMD had a positive cash flow from operations.
Each year in the past 5 years INMD has been profitable.
INMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
INMD's Return On Assets of 25.28% is amongst the best of the industry. INMD outperforms 98.94% of its industry peers.
The Return On Equity of INMD (28.50%) is better than 97.87% of its industry peers.
INMD has a better Return On Invested Capital (16.37%) than 95.74% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INMD is significantly above the industry average of 8.98%.
The 3 year average ROIC (22.96%) for INMD is well above the current ROIC(16.37%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 25.28% | ||
| ROE | 28.5% | ||
| ROIC | 16.37% |
ROA(3y)23.68%
ROA(5y)26.17%
ROE(3y)26.66%
ROE(5y)29.84%
ROIC(3y)22.96%
ROIC(5y)26.04%
1.3 Margins
Looking at the Profit Margin, with a value of 44.58%, INMD belongs to the top of the industry, outperforming 97.87% of the companies in the same industry.
INMD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 28.64%, INMD belongs to the top of the industry, outperforming 96.28% of the companies in the same industry.
In the last couple of years the Operating Margin of INMD has declined.
Looking at the Gross Margin, with a value of 79.98%, INMD belongs to the top of the industry, outperforming 92.55% of the companies in the same industry.
INMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.64% | ||
| PM (TTM) | 44.58% | ||
| GM | 79.98% |
OM growth 3Y-15.14%
OM growth 5Y-5.56%
PM growth 3Y-0.22%
PM growth 5Y3.25%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
2. Health
2.1 Basic Checks
INMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, INMD has less shares outstanding
Compared to 5 years ago, INMD has more shares outstanding
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC8.79%
2.3 Liquidity
INMD has a Current Ratio of 9.54. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.54, INMD belongs to the top of the industry, outperforming 92.02% of the companies in the same industry.
A Quick Ratio of 8.52 indicates that INMD has no problem at all paying its short term obligations.
The Quick ratio of INMD (8.52) is better than 92.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.54 | ||
| Quick Ratio | 8.52 |
3. Growth
3.1 Past
INMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.67%.
The Earnings Per Share has been growing by 22.98% on average over the past years. This is a very strong growth
Looking at the last year, INMD shows a very negative growth in Revenue. The Revenue has decreased by -19.76% in the last year.
The Revenue has been growing by 20.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.98%
EPS Q2Q%-45.71%
Revenue 1Y (TTM)-19.76%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
3.2 Future
Based on estimates for the next years, INMD will show a small growth in Earnings Per Share. The EPS will grow by 1.66% on average per year.
Based on estimates for the next years, INMD will show a small growth in Revenue. The Revenue will grow by 0.63% on average per year.
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.71, which indicates a very decent valuation of INMD.
Compared to the rest of the industry, the Price/Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 94.68% of the companies listed in the same industry.
INMD is valuated cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.99, the valuation of INMD can be described as very cheap.
Based on the Price/Forward Earnings ratio, INMD is valued cheaper than 96.28% of the companies in the same industry.
INMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.71 | ||
| Fwd PE | 7.99 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.94% of the companies listed in the same industry.
97.34% of the companies in the same industry are more expensive than INMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.33 | ||
| EV/EBITDA | 1.74 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.38
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
5. Dividend
5.1 Amount
INMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INMD (11/17/2025, 3:02:08 PM)
13.76
-0.41 (-2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners58.73%
Inst Owner Change2.29%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap869.77M
Revenue(TTM)394.82M
Net Income(TTM)179.00M
Analysts72.31
Price Target16.98 (23.4%)
Short Float %5.35%
Short Ratio3.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.54%
Min EPS beat(2)-13.69%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-3.62%
Min EPS beat(4)-20.27%
Max EPS beat(4)10.61%
EPS beat(8)3
Avg EPS beat(8)-6.64%
EPS beat(12)7
Avg EPS beat(12)-0.75%
EPS beat(16)11
Avg EPS beat(16)1.82%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)-2.38%
Revenue beat(4)1
Avg Revenue beat(4)-3.67%
Min Revenue beat(4)-9.96%
Max Revenue beat(4)0.53%
Revenue beat(8)1
Avg Revenue beat(8)-7%
Revenue beat(12)5
Avg Revenue beat(12)-3.84%
Revenue beat(16)9
Avg Revenue beat(16)-1.49%
PT rev (1m)2.46%
PT rev (3m)2.46%
EPS NQ rev (1m)3.76%
EPS NQ rev (3m)4.64%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-6.54%
Revenue NQ rev (1m)1.64%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-3.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.71 | ||
| Fwd PE | 7.99 | ||
| P/S | 2.17 | ||
| P/FCF | 8.33 | ||
| P/OCF | 8.28 | ||
| P/B | 1.38 | ||
| P/tB | 1.38 | ||
| EV/EBITDA | 1.74 |
EPS(TTM)1.58
EY11.48%
EPS(NY)1.72
Fwd EY12.52%
FCF(TTM)1.65
FCFY12%
OCF(TTM)1.66
OCFY12.07%
SpS6.35
BVpS9.94
TBVpS9.94
PEG (NY)N/A
PEG (5Y)0.38
Graham Number18.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 25.28% | ||
| ROE | 28.5% | ||
| ROCE | 17.94% | ||
| ROIC | 16.37% | ||
| ROICexc | 80.52% | ||
| ROICexgc | 80.52% | ||
| OM | 28.64% | ||
| PM (TTM) | 44.58% | ||
| GM | 79.98% | ||
| FCFM | 26% |
ROA(3y)23.68%
ROA(5y)26.17%
ROE(3y)26.66%
ROE(5y)29.84%
ROIC(3y)22.96%
ROIC(5y)26.04%
ROICexc(3y)533.89%
ROICexc(5y)5031.75%
ROICexgc(3y)533.89%
ROICexgc(5y)5031.75%
ROCE(3y)25.17%
ROCE(5y)28.54%
ROICexgc growth 3Y-60.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y-60.64%
ROICexc growth 5YN/A
OM growth 3Y-15.14%
OM growth 5Y-5.56%
PM growth 3Y-0.22%
PM growth 5Y3.25%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 80.26% | ||
| Cap/Sales | 0.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.7% | ||
| Profit Quality | 58.32% | ||
| Current Ratio | 9.54 | ||
| Quick Ratio | 8.52 | ||
| Altman-Z | N/A |
F-Score7
WACC8.79%
ROIC/WACC1.86
Cap/Depr(3y)144.96%
Cap/Depr(5y)147.97%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.23%
Profit Quality(3y)91.2%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.98%
EPS Q2Q%-45.71%
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.76%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
EBIT growth 1Y-14.01%
EBIT growth 3Y-12.3%
EBIT growth 5Y13.65%
EBIT Next Year-39.83%
EBIT Next 3Y-11.3%
EBIT Next 5YN/A
FCF growth 1Y-40.59%
FCF growth 3Y-8.72%
FCF growth 5Y16.56%
OCF growth 1Y-40.64%
OCF growth 3Y-8.72%
OCF growth 5Y16.42%
INMODE LTD / INMD FAQ
Can you provide the ChartMill fundamental rating for INMODE LTD?
ChartMill assigns a fundamental rating of 7 / 10 to INMD.
What is the valuation status for INMD stock?
ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.
How profitable is INMODE LTD (INMD) stock?
INMODE LTD (INMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of INMODE LTD (INMD) stock?
The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 8.71 and the Price/Book (PB) ratio is 1.38.
What is the financial health of INMODE LTD (INMD) stock?
The financial health rating of INMODE LTD (INMD) is 8 / 10.